Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Maitland, FL
mi
from 43215
Maitland, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Maitland, FL
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Atlanta, GA
mi
from 43215
Atlanta, GA
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Atlanta, GA
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Minneapolis, MN
mi
from 43215
Minneapolis, MN
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Minneapolis, MN
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Greenville, SC
mi
from 43215
Greenville, SC
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Greenville, SC
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Connecticut Children's Hospital Medical Center
553
mi
from 43215
Hartford, CT
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Hospital Medical Center
553
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
432
mi
from 43215
Atlanta, GA
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
2
mi
from 43215
Columbus, OH
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Hospital for Sick Children
316
mi
from 43215
Toronto,
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Hospital for Sick Children
316
mi
from 43215
Toronto,
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
Endoscopy Center of Connecticut, LLC
549
mi
from 43215
Guilford, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
Endoscopy Center of Connecticut, LLC
549
mi
from 43215
Guilford, CT
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
Endoscopy Center of Connecticut, LLC
538
mi
from 43215
Hamden, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
Endoscopy Center of Connecticut, LLC
538
mi
from 43215
Hamden, CT
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  12/31/1969
American Research Corporation at Texas Liver Institute
1136
mi
from 43215
San Antonio, TX
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 12/31/1969
American Research Corporation at Texas Liver Institute
1136
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
984
mi
from 43215
Miami, FL
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
984
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  12/31/1969
APEX GmBH
4421
mi
from 43215
Munich,
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 12/31/1969
APEX GmBH
4421
mi
from 43215
Munich,
Click here to add this to my saved trials
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Novel Oral Peptide BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
Celerion
721
mi
from 43215
Lincoln, NE
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Novel Oral Peptide BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Celerion
721
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Obesity, Iron Regulation and Colorectal Cancer Risk
Obesity, Iron Regulation and Colorectal Cancer Risk
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Chicago
274
mi
from 43215
Chicago, IL
Obesity, Iron Regulation and Colorectal Cancer Risk
Obesity, Iron Regulation and Colorectal Cancer Risk
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Status: Enrolling
Updated:  12/31/1969
Cancer Therapy and Research Center at UTHSCSA
1138
mi
from 43215
San Antonio, TX
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Status: Enrolling
Updated: 12/31/1969
Cancer Therapy and Research Center at UTHSCSA
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.
A Pilot Study Evaluating the Synergistic Effect of Vedolizumab in Conjunction With Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
674
mi
from 43215
Jacksonville, FL
Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.
A Pilot Study Evaluating the Synergistic Effect of Vedolizumab in Conjunction With Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
674
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Transfusions and Nitric Oxide Level in Preterm Infants
Transfusions and Nitric Oxide Level in Preterm Infants
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Transfusions and Nitric Oxide Level in Preterm Infants
Transfusions and Nitric Oxide Level in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Morristown Memorial Hospital/Goyerb Children's Hospital
463
mi
from 43215
Morristown, NJ
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Morristown Memorial Hospital/Goyerb Children's Hospital
463
mi
from 43215
Morristown, NJ
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
A Randomized, Placebo-Controlled, Sequential Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
Status: Enrolling
Updated:  12/31/1969
Landos Biopharma Inc.
mi
from 43215
Blacksburg, VA
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
A Randomized, Placebo-Controlled, Sequential Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
Status: Enrolling
Updated: 12/31/1969
Landos Biopharma Inc.
mi
from 43215
Blacksburg, VA
Click here to add this to my saved trials
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated:  10/7/2008
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated: 10/7/2008
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated:  10/7/2008
Children's Hospital of Pittsburgh of UPMC
165
mi
from 43215
Pittsburgh, PA
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated: 10/7/2008
Children's Hospital of Pittsburgh of UPMC
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Vitamin D Levels in Children With IBD
Optimization of Vitamin D Stores and Its Impact on the Bone Health and Disease Outcomes of Children and Adolescents With IBD.
Status: Enrolling
Updated:  1/27/2009
Children's Hospital Boston
641
mi
from 43215
Boston, MA
Vitamin D Levels in Children With IBD
Optimization of Vitamin D Stores and Its Impact on the Bone Health and Disease Outcomes of Children and Adolescents With IBD.
Status: Enrolling
Updated: 1/27/2009
Children's Hospital Boston
641
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated:  4/27/2009
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated: 4/27/2009
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated:  4/27/2009
Children's Hospital of Pittsburgh of UPMC
165
mi
from 43215
Pittsburgh, PA
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated: 4/27/2009
Children's Hospital of Pittsburgh of UPMC
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated:  12/22/2009
Emory University
435
mi
from 43215
Atlanta, GA
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated: 12/22/2009
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated:  12/22/2009
Consultative Gastroenterology
436
mi
from 43215
Atlanta, GA
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated: 12/22/2009
Consultative Gastroenterology
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #059
491
mi
from 43215
Birmingham, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #059
491
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #042
411
mi
from 43215
Huntsville, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #042
411
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #033
555
mi
from 43215
Montgomery, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #033
555
mi
from 43215
Montgomery, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #067
1651
mi
from 43215
Scottsdale, AZ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #067
1651
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #090
1639
mi
from 43215
Tucson, AZ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #090
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #068
506
mi
from 43215
Jonesboro, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #068
506
mi
from 43215
Jonesboro, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 10
623
mi
from 43215
Little Rock, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 10
623
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #093
655
mi
from 43215
Lowell, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #093
655
mi
from 43215
Lowell, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site 062
1989
mi
from 43215
Fresno, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site 062
1989
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #057
1999
mi
from 43215
Madera, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #057
1999
mi
from 43215
Madera, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #060
1888
mi
from 43215
Palm Springs, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #060
1888
mi
from 43215
Palm Springs, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #095
2030
mi
from 43215
Roseville, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #095
2030
mi
from 43215
Roseville, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #003
2104
mi
from 43215
San Carlos, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #003
2104
mi
from 43215
San Carlos, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #022
1951
mi
from 43215
San Diego, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #022
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #052
1986
mi
from 43215
Santa Monica, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #052
1986
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #086
1955
mi
from 43215
West Covina, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #086
1955
mi
from 43215
West Covina, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 27
1165
mi
from 43215
Lafayette, CO
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 27
1165
mi
from 43215
Lafayette, CO
Click here to add this to my saved trials